Perbedaan Organon Pharma Indonesia Tbk. dan Guna Timur Raya Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Guna Timur Raya Tbk. diperdagangkan di Rp1.075 (kapitalisasi pasar 374,1 M, volume 24 jam 3,49 jt). Perbedaan utamanya: Guna Timur Raya Tbk. jauh lebih besar — sekitar 3,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRUK | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 374,1 M |
Volume | — | 3,49 jt |
Lot | — | 34,89 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Guna Timur Raya (the Company) was established based on Notarial Deed No. 18 dated February 29, 1980 of Notary Jacinta Susanti, SH, under the name of PT Timur Jaya.
Selengkapnya di halaman TRUK →